Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing YiGenCloud Institute is a China-based medical big data and precision medicine company focused on integrating clinical data, genomic data, and bioinformatics algorithms. The company provides data structuring, annotation, knowledge mining, disease modeling, and AI-enabled analytics to support clinical decision-making, real-world evidence studies, and drug R&D. Its offerings appear to be service- and platform-oriented rather than centered on a traditional therapeutic drug pipeline. YiGenCloud highlights applications across oncology, hereditary disease, infectious disease, assisted reproduction, pharmacovigilance, and patient follow-up. The company positions itself as a healthcare data infrastructure and analytics partner for precision medicine in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing YiGenCloud Institute.